Two years follow-up study of the pain-relieving effect of gold bead implantation in dogs with hip-joint arthritis

Gry T Jaeger, Stig Larsen, Nils Søli, Lars Moe, Gry T Jaeger, Stig Larsen, Nils Søli, Lars Moe

Abstract

Seventy-eight dogs with pain from hip dysplasia participated in a six-month placebo-controlled, double-blinded clinical trial of gold bead implantation. In the present, non-blinded study, 73 of these dogs were followed for an additional 18 months to evaluate the long-term pain-relieving effect of gold bead implantation. The recently-published results of the six month period revealed that 30 of the 36 dogs (83%) in the gold implantation group showed significant improvement (p = 0.02), included improved mobility and reduction in the signs of pain, compared to the placebo group (60% improvement). In the long-term two-year follow-up study, 66 of the 73 dogs had gold implantation and seven dogs continued as a control group. The 32 dogs in the original placebo group had gold beads implanted and were followed for a further 18 months. A certified veterinary acupuncturist used the same procedure to insert the gold beads as in the blinded study, and the owners completed the same type of detailed questionnaires. As in the blinded study, one investigator was responsible for all the assessments of each dog. The present study revealed that the pain-relieving effect of gold bead implantation observed in the blinded study continued throughout the two-year follow-up period.

References

    1. Hanssen I. Hip dysplasia (HD) in Norwegian Breton dogs. Evaluation and the progeny grading system, the HD index, in breeding studies. Nor Vet Tidsskr. 2000;112:104–106.
    1. Hedhammar A, Olsson SE, Andersson SA, Persson L, Pettersson L, Olausson A, Sundgren PE. Canine hip dysplasia: study of heritability in 401 litters of German Shepherd dogs. J Am Vet Med Assoc. 1979;174:1012–1016.
    1. Henricson B, Norberg I, Olsson SE. On the etiology and pathogenesis of hip dysplasia: a comparative review. J Small Anim Pract. 1966;7:673–688.
    1. Leighton EA, Linn JM, Willham RL, Castleberry MW. A genetic study of canine hip dysplasia. Am J Vet Res. 1977;38:241–244.
    1. Kapatkin AS, Fordyce HH, Mayhew PD, Smith GK. Canine hip dysplasia: the disease and its diagnosis. Compend Contin Educ Pract Vet. 2002;24:526–538.
    1. Durkes TE. Gold bead implants. Probl Vet Med. 1992;4:207–211.
    1. Bollinger C, Decamp CE, Stajich M, Flo GL, Martinez SA, Bennett RL, Bebchuk T. Gait analysis of dogs with hip dysplasia treated with gold bead implantation acupuncture. Vet Comp Orthop Traumatol. 2002;15:116–122.
    1. Hielm-Bjorkman A, Raekallio M, Kuusela E, Saarto E, Markkola A, Tulamo RM. Double-blind evaluation of implants of gold wire at acupuncture points in the dog as a treatment for osteoarthritis induced by hip dysplasia. Vet Rec. 2001;149:452–456.
    1. Jaeger GT, Larsen S, Søli N, Moe L. Double-blind, placebo-controlled trial of the pain-relieving effects of the implantation of gold beads into dogs with hip dysplasia. Vet Rec. 2006;158:722–726.
    1. Jaeger GT, Larsen S, Moe L. Stratification, blinding and placebo effect in a randomized, double blind placebo-controlled clinical trial of gold bead implantation in dogs with hip dysplasia. Acta Vet Scand. 2005;46:57–68. doi: 10.1186/1751-0147-46-57.
    1. Pibarot P, Dupuis J, Grisneaux E, Cuvelliez S, Plantè J, Beauregard G, Bonneau NH, Bouffard J, Blais D. Comparison of ketoprofen, oxymorphone hydrochloride, and butorphanol in the treatment of postoperative pain in dogs. J Am Vet Med Assoc. 1997;211:438–444.
    1. Hazewinkel HAW, Meutstege FJ. Locomotor system. In: Rijnberk A and de Vries HW, editor. Medical history and physical examination in companion animals. Dordrecht, Kluwer Academic Publisher; 1990. pp. 175–201.
    1. Theiler R, Ghosh P, Brooks P. Clinical, biochemical and imaging methods of assessing osteoarthritis and clinical trials with agents claiming "chondromodulating" activity. Osteoarthritis Cartilage. 1994;2:1–23. doi: 10.1016/S1063-4584(05)80002-0.
    1. Altman DG. Practical statistics for medical research. London, Chapman and Hall; 1999. Comparing groups - continuous data; pp. 179–228.
    1. Agresti A. Categorical Data Analysis. New York, John Wiley & Sons; 1990.
    1. Kleinbaum DG, Kupper LL, Muller KE, Nizam A. Applied regression analysis and other multivariable methods. 3. Pacific Grove, Brooks/Cole Publishing Company; 1998.
    1. Moe L, Bredal W, Glattre E. Census of dogs in Norway. Including numbers from 1992/93, overall mortality rate and calculation of the mass in 1997 of Bernese mountain dog, Boxer and Bichon frisè. Norwegian School of Veterinary Science, Norwegian School of Veterinary Science; 2001. pp. 1–73.
    1. Altman DG. Clinical trials. In: Altman DG, editor. Practical statistics for medical research. London, Chapman & Hall/CRC; 1999. pp. 440–474.
    1. Evans FJ. Expectancy, therapeutic instructions, and the placebo response. In: White L, Tursky B and Schwartz GE, editor. Placebo theory, research, and mechanisms. New York, The Guildford Press; 1985. pp. 215–228.
    1. Batterman RC, Lower WR. Placebo responsiveness - influence of previous therapy. Curr Ther Res Clin Exp. 1968;10:136–143.
    1. Schultz KF, Chalmers IH., R.J.Altman,D.G Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. J Am Med Assoc. 1995;273:408–412. doi: 10.1001/jama.273.5.408.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere